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The Steady-State Repertoire of Human SCF
Ubiquitin Ligase Complexes Does Not Require
Ongoing Nedd8 Conjugation*□S
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Geoffrey T. Smith§, Sonja Hess§, and Raymond J. Deshaies‡¶
The human genome encodes 69 different F-box proteins
(FBPs), each of which can potentially assemble with Skp1-
Cul1-RING to serve as the substrate specificity subunit of
an SCF ubiquitin ligase complex. SCF activity is switched
on by conjugation of the ubiquitin-like protein Nedd8 to
Cul1. Cycles of Nedd8 conjugation and deconjugation
acting in conjunction with the Cul1-sequestering factor
Cand1 are thought to control dynamic cycles of SCF as-
sembly and disassembly, which would enable a dynamic
equilibrium between the Cul1-RING catalytic core of SCF
and the cellular repertoire of FBPs. To test this hypothe-
sis, we determined the cellular composition of SCF com-
plexes and evaluated the impact of Nedd8 conjugation on
this steady-state. At least 42 FBPs assembled with Cul1 in
HEK 293 cells, and the levels of Cul1-bound FBPs varied
by over two orders of magnitude. Unexpectedly, quanti-
tative mass spectrometry revealed that blockade of
Nedd8 conjugation led to a modest increase, rather than a
decrease, in the overall level of most SCF complexes. We
suggest that multiple mechanisms including FBP dissoci-
ation and turnover cooperate to maintain the cellular pool
of SCF ubiquitin ligases. Molecular & Cellular Proteom-
ics 10: 10.1074/mcp.M110.006460, 1–9, 2011.
Proteins in the cell are in a dynamic state—they are con-
tinuously being synthesized and degraded to maintain intra-
cellular protein homeostasis. The majority of intracellular pro-
tein degradation is controlled by the ubiquitin-proteasome
system. Ubiquitin-proteasome system-mediated protein deg-
radation comprises two major successive steps (1, 2). The
first step is the covalent assembly of a chain of the small
protein ubiquitin on target proteins. This first step is catalyzed
by the sequential action of three different classes of enzymes.
Ubiquitin-activating enzyme (E1) catalyzes the activation of
ubiquitin, which is subsequently transferred to ubiquitin-con-
jugating enzyme (E2). E2 charged with ubiquitin collaborates
with ubiquitin ligase (E3) to ubiquitylate the target substrate.
Multiple ubiquitin transfers may occur in a successive man-
ner, resulting in the processive formation of an ubiquitin chain
(3). The second step is the energy-dependent proteolysis of
the ubiquitin chain-tagged protein by the 26S proteasome
complex.
There are nearly 600 ubiquitin ligases encoded in the hu-
man genome, and up to 241 (over 40%) are potentially drawn
from the cullin–ring ligase (CRL)1 family (K. Hofmann, personal
communication). The biological significance of CRLs is man-
ifested by the fact that about 20% of the proteasome-de-
pendent cellular protein degradation is dependent on CRL
activity (4). CRLs are modular multisubunit complexes com-
posed of a cullin subunit that serves as an organizing scaffold,
an E2-recruiting RING subunit, an adaptor protein, and a
substrate recognition subunit (5). In the SCF complex (Skp1
adaptor; Cul1 scaffold; F-box substrate recognition subunit),
the prototypical CRL, common subunits are shared except for
the F-box protein (FBP) that recruits substrate. Thus, the
enzymatic identity of an SCF complex is designated by its
FBP subunit. Up to 69 loci that encode FBPs are found in the
human genome, alluding to the possibility of the same number
of different SCF complexes (6). It is a matter of debate,
however, whether all 69 FBPs can assemble into an SCF
complex. For example, the yeast FBPs Ctf13 and Rcy1 do not
form stable complexes with Cul1 (7, 8). Of the 69 possible
SCF complexes, several have been identified and investigated
in great detail, but the vast majority remains to be explored.
A second unresolved question about the network of SCF
ubiquitin ligases is, how is the assembly of 69 different SCF
complexes regulated? We and others (9–11) have proposed
that the Cul1-RING (the SCF RING subunit is known as either
Rbx1, Roc1, or Hrt1) catalytic core of SCF cycles dynamically
between an assembled, active state and a disassembled,
inactive state (hereafter referred to as the “Cul1 cycle”) (Fig.
1). The active state is represented by Cul1 bound to FBP-
Skp1 and conjugated with the ubiquitin-like modifier Nedd8 at
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Lys720. This modification (neddylation) causes a major con-
formational change in the cullin and RING subunits (12), and
increases ubiquitin ligase activity (12–14). Inactivation of SCF
is initiated by deconjugation of Nedd8 (deneddylation) by the
COP9 signalosome complex (CSN) (15), which houses a met-
allo-isopeptidase subunit (9). Once deneddylated, Cul1 be-
comes available to the sequestration factor Cand1, which
dislocates FBP-Skp1 to establish an enzymatically inactive
Cand1-Cul1 complex (16, 17). Because Cand1 partially oc-
cludes both the FBP-Skp1 binding site and Lys720 on Cul1,
the active and inactive states of Cul1 are mutually exclusive.
The Cul1 cycle is completed by the dissolution of the Cand1-
Cul1 complex by the combined action of Nedd8-conjugating
enzymes and FBP-Skp1, resulting in the reformation of an
intact, Nedd8-conjugated SCF complex (18, 19). It has been
suggested that dynamic cycles of assembly/disassembly
remodel the repertoire of SCF complexes in accordance
with cellular requirements (9, 11). Although this hypothesis
is attractive, many of its predictions remain to be tested.
Specifically, it remains unclear whether SCF complexes
undergo cycles of assembly/disassembly in cells, and to
what extent such cycles are driven by Nedd8 conjugation
and deconjugation.
Here, we probe the Cul1 network and the proposed Cul1
cycle using mass spectrometry. First, we determined the rep-
ertoire of SCF complexes in HEK 293 cells. We found at least
42 FBPs assembled with Cul1 in HEK 293 cells, with abun-
dance of the complexes varying over two orders of magni-
tude. Second, we tested a key prediction of the current model
for how SCF complexes dynamically assemble and disassem-
ble by evaluating the composition of SCF complexes in cells
in which Nedd8 conjugation was blocked by the inhibitor
MLN4924 (4). According to the current model, loss of Cul1
neddylation is predicted to bring about a shift in the SCF
equilibrium in favor of disassembly. Using the quantitative
stable isotope labeling with amino acid in cell culture (SILAC)
approach, we show that MLN4924 actually increased FBP-
Skp1 association with Cul1.
EXPERIMENTAL PROCEDURES
Chemicals and Reagents—MagneHis Ni-Particles and sequencing
grade trypsin were purchased from Promega. High Capacity Neutra-
vidin Agarose Resin, n-dodecyl--D-maltoside, and SuperSignal West
Dura Extended Duration chemiluminescent substrate were obtained
from Thermo Scientific. Lysyl endopeptidase (LysC) was obtained
from Wako Chemicals (Richmond, Va). Cell culture reagents, Flip-In
T-REx 293 cells, plasmids, and monoclonal antibodies for Cul1 and
Cand1 were obtained from Invitrogen. Plasmid DNA containing the
human Cul1 sequence was purchased from Open Biosystems.
MLN4924 was a generous gift from Millennium: The Takeda Oncology
Company. All other general chemicals for buffers were purchased
from Fisher Scientific and/or VWR International.
Plasmid and Cloning—The HTBH tag (20) was a generous gift from
the Kaiser group. This tag contains a TEV cleavage site, two hexa-His
sequences, and a biotinylation signal sequence. Biotinylation is cat-
alyzed by endogenous biotin ligases, which are present in all eukary-
otic cells (21). The HTBH tag was appended to the C terminus of the
human Cul1 and sequences encoding Cul1HTBH were inserted into the
pCDNA5/FRT/TO plasmid.
Construction of Stable Cell Line—Flip-In T-REx 293 cells contain a
single stably integrated FRT site at a transcriptionally active genomic
locus. For targeted integration of CUL1HTBH into the FRT site, co-
transfection of Cul1HTBH/pCNDA5/FRT/TO vector and Flp recombi-
nase vector pOG44 was performed using Lipofectamine 2000 (Invitro-
gen). One day after transfection, 100 g/ml hygromycin was added to
the medium to select for the cells with intergrated sequences coding
for Cul1HTBH. It took 2 weeks for visible colonies to appear. Five
colonies were picked and expanded to confirm tetracycline-depen-
dent expression of Cul1HTBH. Expanded colonies were grown in me-
dium containing 10% fetal bovine serum, 1% penicillin/streptomy-
cin, and 50 g/ml hygromycin. For SILAC, Dulbecco’s modified
Eagles medium (DMEM) lacking arginine and lysine was used, along
with 10% dialyzed fetal bovine serum. For heavy labeling, Arg6
(U-13C6) and Lys8 (U-13C6, U-15N2) (Cambridge Isotopes, Andover,
MA) were supplemented at the same concentration as in the stan-
dard DMEM formulation. For light labeling, regular DMEM was
used. Following 10 passages in heavy medium, label incorporation
rates were measured by acid hydrolysis of lysates as described
previously (22).
Two-step Purification of Cul1HTBH—To induce the expression of
HTBH-tagged Cul1 in cells at 50% confluency, 1.0 g/ml tetracycline
was added to the medium for 4 h. This expression condition ensured
that the level of tagged Cul1 was similar to that of endogenous Cul1.
Following induction, cells were allowed to grow for 24 h. Deneddyla-
tion of Cul1 was effected by treating Cul1-induced cells with 100 nM
MLN4924 for 24 h. Cells were trypsinized and washed two times with
ice-cold phosphate buffered saline buffer. The cell pellets were col-
lected and lysed in lysis buffer (50 mM HEPES, pH 7.5; 70 mM KOAc;
5 mM Mg(OAc)2; 20 mM imidazole, 0.2% n-dodecyl--D-maltoside)
containing 1 protease inhibitor (Roche) for 30 min on a gyrating
platform at 4 °C. The lysates were centrifuged at 16,600  g for 15
FIG. 1. The Cul1 Cycle. A, Cul1 complexed with FBP-Skp1 and
covalently modified with Nedd8 (N8) represents an active SCF. B
and C, Inactivation of SCF initiates when CSN binds active SCF and
deconjugates Nedd8, returning the RING subunit Rbx1 to its inactive
configuration. D, Cand1 dislocates FBP-Skp1 and binds Cul1, form-
ing an inactive Cand1-Cul1 complex. Restoration of an active SCF
complex is brought upon by the combined action of Nedd8-conju-
gating enzymes and FBP-Skp1. Conjugation of Nedd8 causes a
major conformational change in Cul1 and E2-recruiting Rbx1. This
dynamic cycle of Cul1 is thought to enable a rapid sampling of the
steady-state FBP-Skp1 population.
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min to remove cell debris, and the supernatant was incubated with
MagneHis Ni particles (30 l particles/mg lysate) on a gyrating plat-
form for 90 min at 4 °C. The MagneHis particles were then washed
with 20 bed volumes of the lysis buffer three times, followed by a
10-min elution with 10 bed volumes of elution buffer (50 mM HEPES,
pH 7.5; 70 mM KOAc; 5 mM Mg(OAc)2; 300 mM imidazole, 0.2%
n-dodecyl--D-maltoside). Eluant was incubated with Neutravidin
beads (10 l beads/mg lysate) on a gyrating platform for 90 min at
4 °C. Neutravidin beads were washed with lysis buffer three times and
then washed with 100 mM Tris-HCl (pH 8.5) two times.
Mass Spectrometric Analysis—At the last step of the tandem affin-
ity purification, the proteins were bound on Neutravidin beads for a
direct on-bead digestion. Digestion was performed in 100 mM Tris-
HCl (pH 8.5) containing 8 M urea at 37 °C first with Lys-C (35 ng/mg
lysate) for 4 h, and then the urea concentration was reduced to 2 M for
trypsin (30 ng/mg lysate) digestion overnight. Following digestion, the
tryptic peptides were desalted on a reversed-phase Vivapure C18
micro spin column (Sartorius Stedim Biotech, Gottingen, Germany),
and concentrated using a SpeedVac. Dried samples were acidified by
0.2% formic acid prior to mass spectrometric analysis. All liquid
chromatography-mass spectrometry experiments were performed on
an EASY-nLC (Proxeon Biosystems, Waltham, MA) connected to a
hybrid LTQ-Orbitrap Classic (Thermo Scientific) equipped with a na-
no-electrospray ion source (Proxeon Biosystems) essentially as pre-
viously described (23) with some modifications. Peptides were sep-
arated on a 15 cm reversed phase analytical column (75 m internal
diameter) packed in-house with 3 m C18AQ beads (ReproSil-Pur
C18AQ) using a 160-min gradient from 12% to 30% acetonitrile in
0.2% formic acid at a flow rate of 350 nL/minute. The mass spec-
trometer was operated in data-dependent mode to automatically
switch between full-scan MS and tandem MS acquisition. Survey full
scan mass spectra were acquired in Orbitrap (300–1700 m/z), follow-
ing accumulation of 500,000 ions, with a resolution of 60,000 at 400
m/z. The top ten most intense ions from the survey scan were isolated
and, after the accumulation of 5000 ions, fragmented in the linear ion
trap by collisionally induced dissociation (collisional energy 35% and
isolation width 2 Da). Precursor ion charge state screening was enabled
and all singly charged and unassigned charge states were rejected. The
dynamic exclusion list was set with a maximum retention time of 90 s,
a relative mass window of 10 ppm and early expiration was enabled.
The raw data can be downloaded from Tranche at https://
proteomecommons.org/dataset.jsp?iCE7O4IntpkSJ7mnej1%252FT
Wma0CVpb4rjb1XFI2LjQ%252BV4cnzIMGTVnj%25
Data Analysis—Peak lists were generated from raw data files using
MaxQuant (version 1.0.13.13) (24). Peak lists were then submitted
to the database search engine Mascot (version 2.2.06; www.
matrixscience.com) and searched against the IPI human database (v
3.54) and a contaminant database concatenated to a decoy database
prepared as described in (24). There were 75,668 target database
sequences with 262 contaminant sequences, and an equal number of
decoy sequences. The search parameters were tryptic digestion,
maximum of two missed cleavages, fixed carboxyamidomethyl mod-
ifications of cysteine, variable oxidation modifications of methionine,
and variable protein N-terminal carbamylations. Mass tolerance for
precursor ions were 7 ppm and that for fragment ions were 0.5 Da.
Protein inference and quantitation were performed by MaxQuant with
1% false discovery rate thresholds for both peptides and proteins.
Using our stringent setting, at least two different peptide sequences
were required for protein identification and two different ratio mea-
surements were required for protein quantitation. When single pep-
tide identifications were also accepted, two additional FBPs (Fbxo20
and Fbxl6) were identified and quantified. Peptide intensities from the
unique peptides were used for quantitation. To estimate the reliability
of the fold changes for the SILAC data, the total number of indepen-
dent ratio measurement is given as well as the 95% confidence
interval of the median of all measurements, which was calculated by
bootstrap estimation. For emPAI value calculation, modified and
shared peptides were included for counting.
RESULTS
Generation of Stable Cell Line Expressing Tagged Cul1—To
create a system that would facilitate the purification of Cul1
and its interacting proteins, we constructed a stable cell line
that expressed HTBH-tagged Cul1 (Cul1HTBH) upon tetracy-
cline treatment. Flip-In T-Rex 293 cells cotransfected with the
pCDNA5/FRT/TO vector containing sequences encoding
Cul1HTBH and the pOG44 plasmid encoding recombinase
yielded visible colonies in 2 weeks under selective medium
(100 g/ml hygromycin). Individual colonies were tested for
the level of Cul1HTBH expression (Fig. 2). Western blot analysis
confirmed that tagged Cul1 was expressed at the same level
as the endogenous protein, which should diminish any non-
physiological protein-protein interactions that may be caused
by overexpression. The induction condition described (1.0
g/ml tetracycline, 4 h) was used for all of the experiments
involving the expression of Cul1HTBH.
Analyses of Cul1 Proteome—To reveal the Cul1 proteome,
we carried out liquid chromatography (LC)-tandem MS (MS/
MS) (LTQ-Orbitrap) analyses of the Cul1-associated proteins
following tandem affinity purification of Cul1HTBH. To gain a
comprehensive picture, we analyzed 22 biological replicates,
because we reasoned that the peptides from low abundance
proteins might fall below the range of detection in any single
analysis. As expected, some FBPs were found only in a few
experiments (supplemental Table S1), confirming the validity
of our approach. Overall, we detected 42 different FBPs,
Skp1, Rbx1/Roc1/Hrt1, all the subunits for CSN, Cand1 and
Cand2, and 4 Dcn1-like proteins (Table I). This list comprises
the largest recorded Cul1 proteome to date. Strikingly, no
ubiquitin-conjugating enzymes (E2) were detected.
A recent report suggested that the proline residue in the
conserved LP motif of the F-box is important for distinguish-
ing between FBPs that associate with Cul1 from those that do
FIG. 2. Generation of a stable cell line expressing tagged Cul1
upon tetracycline treatment. Flip-In T-REx 293 cells were trans-
fected with pCDNA5/FRT/TO vector containing sequences encoding
Cul1HTBH, and selected with hygromycin (100 g/ml). Selected cells
were induced with the indicated amount of tetracycline for 4 h (Lane
1, no tetracycline; Lane 2, 0.2 g/ml, Lane 3, 0.5 g/ml; Lane 4, 1.0
g/ml). After induction, cells were grown for 24 h and lysed for
Western blot analysis.
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not (10). Nevertheless, the FBPs we identified in Cul1HTBH
immuno-precipitates included ones that lack this proline res-
idue (e.g. Fbxl18 and Fbxl14; alignment based on the Pfam
database model (25)) (supplemental Table S2). Extensive
bioinformatic searches failed to identify a characteristic motif
that distinguished FBPs found in CulHTBH immuno-precipi-
tates from those not found. It is possible that most of the
undetected FBPs were not expressed in HEK 293 cells or
were expressed at a level that was too low to detect. A
summary of all human F-boxes is described in sup-
plemental Table S2.
To estimate the abundance of individual Cul1-associated
proteins, we adopted emPAI (Exponentially Modified Protein
Abundance Index). This index offers approximate, label-free,
relative quantification of proteins based on peptide recovery
(26). The emPAI value for the detected FBPs ranged from
0.0036 to 1.02, with Skp2 scoring the highest number.
Whereas some highly abundant FBPs have been popular
subjects of study as indicated by their frequency of appear-
ance in PUBMED keyword searches (e.g. Skp2, 625 publica-
tions; Fbxw1a, 303 publications), it is interesting to note that
many of the most abundant FBPs await future characteriza-
tion (Fig. 3).
Among shared Cul1 interactors, Rbx1 had the highest em-
PAI value of 3.08, followed by Skp1 (2.08) and Cand1 (1.7).
The high emPAI value of Rbx1 is consistent with it being a
stoichiometric binding partner of Cul1 (16, 27). We found
every subunit of CSN with emPAI values (0.39–1.33) compa-
rable to those of abundant FBPs. This finding, whereas con-
sistent with immuno-precipitation data, is unusual considering
that the nature of CSN-Cul1 association is that of enzyme-
substrate/product interaction, which in general is transient.
Deneddylation Does not Have a Major Effect on Cul1 Pro-
teome—The current model for SCF regulation posits that Cul1
constantly cycles between states in which it is bound to either
the sequestration factor Cand1 or to FBP-Skp1 complexes (9,
10). This cycle is thought to be fueled by the enzymes that
TABLE I
Summary of proteins associated with Cul1
Proteinsa
Spectral
countsb
Number of
observable
peptidesc
Number of
observed
peptides
emPAId
Cul1 15815 631 117 0.53
Cand1 11218 303 131 1.7
Cand2 372 271 34 0.33
Skp1 1725 43 21 2.08
Rbx1 736 18 11 3.08
Dcn1-like
Dcund1 183 90 15 0.47
Dcund2 4 92 3 0.078
Dcund4 56 117 8 0.17
Dcund5 179 81 20 0.77
Signalosome
Csn1 651 168 27 0.39
Csn2 800 153 38 0.77
Csn3 698 85 31 1.31
Csn4 969 134 35 0.82
Csn5 604 79 29 1.33
Csn6 557 66 21 1.08
Csn7a 241 92 17 0.53
Csn7b 276 80 15 0.54
Csn8 340 30 11 1.33
F-box
Fbxl18 788 167 43 0.90
Fbxo7 653 117 25 0.64
Skp2 (Fbxl1) 646 85 26 1.02
Fbxo21 532 122 30 0.76
Fbxo9 393 153 29 0.55
Fbxo18 173 334 27 0.20
Fbxo42 299 118 25 0.63
Fbxo22 310 102 23 0.68
Fbxw11 232 179 25 0.38
Fbxo44e 278 83 12 0.40
Fbxo17 259 93 17 0.52
Fbxl15 227 121 20 0.46
Fbxo3 226 119 24 0.59
Fbxw1a 133 213 14 0.16
Fbxo38 12 328 5 0.036
Fbxo11 152 174 20 0.30
Fbxo10 10 278 3 0.025
Fbxo30 152 132 21 0.44
Fbxo44f 194 63 12 0.55
Fbxo46 54 190 10 0.13
Fbxo4 159 75 13 0.39
Fbxl12 120 100 14 0.38
Fbxw9 100 115 17 0.41
Fbxl14 76 123 11 0.29
Fbxo5 19 175 7 0.096
Fbxw8 64 123 12 0.25
Fbxo31 27 154 10 0.16
Fbxo33 37 142 6 0.10
Fbxw4 7 172 2 0.027
Fbxw5 31 130 7 0.13
Fbxl20 26 129 8 0.15
Fbxo28 13 139 4 0.069
Fbxl17 6 142 2 0.033
Fbxo6 65 81 7 0.22
Fbxl6 6 139 1 0.017
Fbxl8 45 99 8 0.20
Fbxo25 3 130 2 0.036
TABLE I—continued
Proteinsa
Spectral
countsb
Number of
observable
peptidesc
Number of
observed
peptides
emPAId
Fbxw2 14 110 6 0.13
Fbxl4 13 106 11 0.23
Fbxo8 31 84 9 0.28
Fbxo20 2 642 1 0.0036
Fbxo45 13 76 4 0.13
a Total spectral counts in 22 biological replicates.
b Proteins are filtered at a 1% false discovery rate.
c Observable peptides are defined as tryptic peptides with mass
between 600 and 4500 Da calculated by an in-house script, allowing
up to three mis-cleavages from the first leading protein sequence.
d emPAI  10(# of observed peptides/# of observable peptides) – 1.
e International Protein Index IPI00013239.
f International Protein Index IPI00414844.
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promote conjugation and deconjugation of Nedd8. Conjuga-
tion of Nedd8 to Lys720 of Cul1 promotes dissociation of the
Cand1-Cul1 complex and thereby facilitates incorporation of
Cul1 into an active SCF complex, whereas deconjugation of
Nedd8 by CSN enables resequestration of Cul1 into a com-
plex with Cand1. According to this model, blockade of Nedd8
conjugation should lead to rapid depletion of SCF complexes
as Cul1 becomes deneddylated by CSN and captured by
Cand1. To assess the dynamic behavior of the Cul1 cycle, we
sought to perturb Cul1 neddylation with MLN4924. MLN4249
exerts its deneddylating activity by forming a covalent, irre-
versible adduct with Nedd8 (28). The Nedd8-MLN4924 ad-
duct binds tightly to NAE, blocking the action of this enzyme.
Strikingly, upon treatment with MLN4924 nearly all neddy-
lated Cul1 is depleted within 5 min (4); this result indicates that
Cul1 is subject to continuous, rapid deneddylation by CSN,
implying that the Cul1 cycle runs constitutively at a rapid rate.
The properties of MLN4924 suggested that it would be an
ideal agent to test the current model for SCF dynamics, and
so we sought to evaluate the effect of MLN4924 on the Cul1
proteome using SILAC (stable isotope labeling with amino
acid in cell culture)-based quantitative mass spectrometry.
We first confirmed the impact of MLN4924 on Cul1HTBH
neddylation. Fig. 4 shows that 100 nM MLN4924 drove near
complete elimination of Nedd8 from both endogenous Cul1
and Cul1HTBH. We next carried out SILAC experiments,
wherein parallel cultures of HEK 293 cells expressing
Cul1HTBH were grown, with one culture labeled with light
amino acids and the other labeled with heavy arginine and
lysine (Arg6 and Lys8). These cultures were either mock-
treated or supplemented with 100 nM MLN4924 for 24 h,
following which the cells were mixed, lysed and Cul1HTBH
complexes were retrieved by immuno-precipitation and ana-
lyzed by mass spectrometry. Table II summarizes the results
from 10 independent analyses. Our original expectation was
that the net deneddylation caused by MLN4924 treatment
would have reciprocal effects on Cand1 and FBP-Skp1 asso-
ciation with Cul1, with Cand1 association increasing and
FBP-Skp1 association decreasing. On the contrary, the
amount of Cand1 bound to Cul1 slightly decreased in
MLN4924-treated cells, whereas the amount of Skp1 (up by
1.19-fold) and FBPs (up by 1.30-fold on average) slightly
increased. Similar results were obtained when shorter
MLN4924 treatments were applied (4 and 8 h, data not
shown), and regardless of whether the MLN4924-treated cul-
ture was encoded with light or heavy amino acids. These
results are opposite to what the current model predicts, and
indicate that Nedd8 deconjugation does not lead to the net
loss of SCF complexes.
Free Cand1 is Not Limiting in MLN4924-treated cells—One
potential problem with the approach described above is that
it did not exclude the possibility that the inhibition of neddy-
lation triggered the complete arrest of the Cul1 cycle. For
example, consider the possibility that the molecule of Cand1
that promotes disassembly of one SCF complex is liberated
by assembly of another SCF complex—that all of the Cand1 in
a cell is bound to cullins, and disassembly of SCF complexes
requires the continuous liberation of Cand1 by ongoing ned-
dylation. In this view, shutting off Nedd8 conjugation would be
equivalent to shutting off the spigot that supplies Cand1,
thereby “freezing” the Cul1 cycle. In this case, one would not
observe the expected effect of deneddylation (i.e. increased
Cand1 and decreased Skp1 and FBPs bound to Cul1), if there
is little pre-existing free Cand1. To test this possibility, we
designed a simple reversed order-of-addition experiment. Un-
like the SILAC experiments, the MLN4924 treatment was
initiated prior to the induction of Cul1HTBH synthesis by tetra-
cycline. Newly synthesized Cul1HTBH was affinity-purified and
the amount of Cand1 retrieved was compared with a mock-
treated sample. If free Cand1 becomes limiting in MLN4924-
treated cells because of stoppage of the Cul1 cycle, Cul1HTBH
synthesized following MLN4924 treatment would not have
access to Cand1; therefore, the level of Cand1 associated
with newly-synthesized Cul1HTBH should be much less in
FIG. 3. Correlation of the emPAI values and number of Pubmed
articles for F-box proteins. Representative F-box proteins that are
either intensively studied or found at high levels in Cul1 immuno-
preciptates are labeled.
FIG. 4. Effect of MLN4924 on the neddylation status of Cul1.
Flip-In T-REx 293 cells with an integrated CUL1-HTBH gene (Fig. 2)
were induced with 1.0 g/ml tetracycline for 8 h. Cells were grown
24 h before being treated with the indicated amount of MLN4924 for
an additional 24 h (Lane 1, no MLN4924; Lane 2, 100 nM; Lane3, 50
nM, Lane 4, 10 nM, Lane 5, 5 nM). Cells were lysed with lysis buffer
containing 1 mM 1,10-phenanthroline, a zinc chelator that blocks the
deneddylating activity of the COP9 signalosome (CSN). Neddylated
species for both Cul1HTBH and the endogenous Cul1 are indicated
with the asterisk marks.
Molecular & Cellular Proteomics 10.5 10.1074/mcp.M110.006460–5
MLN4924-treated cells compared with cells that were not
exposed to MLN4924. Yet, Western blot analyses showed
that the amount of Cand1 associated with Cul1HTBH was
almost identical regardless of whether the Cul1HTBH was syn-
thesized in cells exposed to MLN4924 for either 15 min. or
24h, or mock-treated (Fig. 5). This result is consistent with
absolute quantification of the free and bound pools of Cand1
(J.W. Harper, personal communication) and confirms that
there is enough free Cand1 available for complex formation
with Cul1 even after the complete loss of Nedd8 conjugation.
DISCUSSION
CRLs represent approximately one third of human ubiquitin
ligases. Despite a strong emerging consensus that CRLs play
key roles in diverse aspects of human biology, several funda-
mental questions remain unanswered including, how are the
assembly and cellular repertoire of these modular, multisub-
unit ligases dynamically regulated? To address these issues,
we took a quantitative proteomic approach with Cul1, which
serves as the organizing scaffold of SCF, the prototype for the
CRL family. We first obtained a static representation of the
FIG. 5. Effect of MLN4924 on the availability of free Cand1.
Flip-In T-REx 293 cells with an integrated CUL1-HTBH gene were
mock-treated or treated with MLN4924 (3 M MLN4924 for 15 min
treatment and 100 nM MLN4924 for 24 h treatment) prior to tetracy-
cline induction. Following this first treatment period, Cul1HTBH was
expressed with 2 g/ml tetracycline for 2 h, keeping MLN4924 pres-
ent in the MLN4924-treated samples. Following cell lysis, newly syn-
thesized Cul1HTBH was affinity purified, and the amount of Cul1-
bound Cand1 was analyzed by Western blot.
TABLE II—continued
Proteinsa Fold changeb,c
Number of
ratio measurementsd
Fbxo11 0.67 (0.61–0.87) 83
Fbxl3 0.31 (0.26–2.03) 5
Average F-box 1.30
a Proteins are filtered at a 1% false discovery rate.
b Median values for H/L from the SILAC experiments where heavy
cells are treated with 100 nM MLN4924 for 24 hours. When light cells
were treated with MLN4924, H/L was reversed. Values were normal-
ized so that H/L for Cul1 was 1.
c 95% confidence interval calculated by bootstrap estimation is
shown in the parentheses.
d Peptides from ten biological replicates were used for quantitation
by the program MaxQuant.
e International Protein Index IPI00647771.
f International Protein Index IPI00414844.
TABLE II
Quantitative analysis of proteins associated with Cul1 upon inhibition
of neddylation
Proteinsa Fold changeb,c
Number of
ratio measurementsd
Cul1 1.00 (0.99–1.01) 4154
Cand1 0.92 (0.91–0.93) 2584
Skp1 1.19 (1.16–1.21) 476
Rbx1 1.00 (0.97–1.02) 183
Dcn1-like
Dcund1 0.85 (0.82–0.91) 22
Dcund2 0.95 (0.80–1.07) 6
Dcund4 0.93 (0.85–1.02) 14
Dcund5 0.94 (0.88–0.98) 172
Signalosome
Csn1 0.98 (0.96–1.00) 472
Csn2 1.01 (0.93–1.13) 13
Csn3 0.98 (0.96–1.00) 460
Csn4 0.96 (0.94–0.98) 648
Csn5 0.95 (0.94–0.98) 348
Csn6 0.99 (0.98–1.02) 315
Csn7a 0.91 (0.87–0.94) 182
Csn7b 1.02 (0.98–1.07) 158
Csn8 1.01 (0.97–1.04) 156
F-box
Fbxo18 2.06 (2.01–2.20) 155
Fbxw5 2.04 (1.86–2.24) 16
Fbxl6 2.04 (1.59–2.49) 7
Fbxl17 1.91 (1.20–3.24) 6
Fbxo46 1.90 (1.36–2.99) 16
Fbxo31 1.79 (1.71–2.06) 25
Fbxw1a 1.60 (1.49–1.74) 40
Fbxo21 1.52 (1.45–1.57) 234
Fbxo38 1.51 (1.24–1.67) 13
Fbxo33 1.50 (1.40–1.62) 47
Fbxo22 1.50 (1.43–1.55) 139
Fbxo28 1.49 (1.29–1.59) 11
Fbxo17 1.48 (1.38–1.54) 40
Skp2 (Fbxl1) 1.42 (1.39–1.49) 201
Fbxw2 1.42 (1.29–1.62) 10
Fbxw9 1.31 (1.27–1.47) 61
Fbxo44e 1.30 (1.22–1.46) 37
Fbxl20 1.29 (1.20–1.31) 3
Fbxw11 1.28 (1.25–1.34) 89
Fbxo5 1.24 (1.12–1.38) 10
Fbxo30 1.23 (1.17–1.28) 114
Fbxo7 1.21 (1.16–1.28) 244
Fbxl12 1.20 (1.15–1.25) 95
Fbxo42 1.19 (1.12–1.25) 123
Fbxo3 1.14 (1.10–1.18) 107
Fbxo6 1.13 (0.98–1.30) 7
Fbxo44f 1.11 (1.05–1.20) 28
Fbxl14 1.09 (1.05–1.14) 36
Fbxo10 1.07 (0.85–1.09) 11
Fbxl18 1.05 (1.02–1.08) 258
Fbxo4 1.03 (0.97–1.12) 44
Fbxl8 1.03 (0.93–1.08) 29
Fbxw8 1.01 (0.98–1.06) 47
Fbxl15 1.01 (0.96–1.17) 91
Fbxo45 0.97 (0.27—1.05) 7
Fbxo8 0.96 (0.90–1.23) 17
Fbxo9 0.93 (0.91–0.97) 206
Fbxw4 0.92 (0.78–0.95) 4
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Cul1 proteome, surveying howmany different SCF complexes
can be detected in a single cell type. Using a HEK 293-derived
cell line that expresses a tandem-tagged Cul1 at levels similar
to the endogenous protein, we determined that Cul1 inter-
acted with at least 42 different FBPs. Thus, at least 60% of the
FBPs encoded in the human genome can form SCF com-
plexes with Skp1-Cul1-Rbx1. We did not detect five FBPs
that are known to interact with Cul1 (Fbxo1, Fbxo2, Fbxo32,
Fbxl5, and Fbxw7), presumably because of their low (or lack
of) expression in HEK 293 cells; thus, 47 represents the min-
imum estimate of the number of different SCF complexes that
can form in human cells.
In addition to FBPs, our proteomic analysis detected the
known shared core subunits including Rbx1 and Skp1, as well
as the regulatory factors Cand1 and 2, Dcund1, 2, 4, and 5,
and CSN. It is worthwhile to mention that we did not detect
any E2 enzymes in our analyses. Identifying the physiological
E2 partner for an E3 ubiquitin ligase is of great importance,
because E2 enzymes are thought to determine the nature of
the ubiquitin chain attached to the target substrate, which
determines the subsequent cellular fate of the conjugate.
Failure to detect an E2 enzyme is consistent with the obser-
vation that SCF-Cdc34 (Cdc34 is an E2 for SCF) interactions
are extremely transient (29), and thus were presumably lost
during the affinity purification step. In this regard, we still lack
a reliable methodology for determining the complete function-
ally-relevant proteome for SCF ubiquitin ligases by mass
spectrometry.
Among identified binders of Cul1, FBPs are of special in-
terest because these proteins render substrate specificity to
the SCF complex. FBPs are classified into three major sub-
categories—FBXLs, FBXWs, and FBXOs—based on the type
of substrate interaction domain linked to the F-box (6). As
shown in Table I, we found all three F-box subclasses in
association with Cul1. Based on a recent report that a critical
proline residue within the F-box determines whether a given
FBP assembles with Cul1 (10), we performed extensive bioin-
formatic analyses focusing on the 40-amino acid F-box. Our
data do not reveal a motif that distinguishes FBPs that were
detected Cul1 immuno-precipitates from those that were not
and are in conflict with the prior report, because three of the
FBPs detected in our experiments lack the critical proline
(supplemental Table S2). It is possible, however, that these
proline-less FBPs interact indirectly as a substrate or di-
merize with proline-containing FBPs (30, 31).
Our data indicate that HEK 293 cells assemble at least 42
different SCF complexes, each defined by its characteristic
FBP subunit. Skp1-Cul1-Rbx1 is not shared equally by the
different FBPs, in that FBP abundance (estimated based on
emPAI values) varied by two orders of magnitude. Future work
will reveal whether this variation is driven by differences in
expression level versus differences in assembly. It seems
likely that some less abundant SCF complexes were left un-
identified because of limits to the sensitivity of the methodol-
ogy used in this study, so the difference in abundance could
be even more significant. A close assessment of the emPAI
values for the identified FBPs shed light on another inter-
esting aspect of our findings. With Skp2 exhibiting the high-
est emPAI value of 1.02, SCFSkp2 could be considered to be
one of the most abundant SCF complexes in HEK 293 cells.
Skp2 is also the most intensively studied FBP. A search of
the PUBMED database with the keywords skp2, fbl1, or
fbxl1 yielded 625 papers, which is the greatest number
among all F-box proteins (Fig. 3). Skp2 was one of the first
human FBPs to be discovered (32), which was enabled by
its relative abundance. It is therefore most intriguing to
consider that of the ten FBPs on our list with the highest
emPAI values, eight are poorly (or not at all) characterized.
For example, Fbxl18 and Fbxo21, the FBPs with the highest
emPAI values and the highest total spectral counts, have
zero references in the PUBMED database. The combined
reference count for these eight poorly studied F-box pro-
teins is only 27. This simple fact highlights that there is a
great amount that remains to be learned about the biology
of SCF complexes.
Given the large number of distinct FBP-Skp1 complexes in
human cells that compete for a common Cul1-Rbx1 catalytic
core, a key question is, how is the cellular repertoire of SCF
complexes controlled? Several lines of evidence suggest that
SCF complexes undergo constant cycles of assembly and
disassembly, and this allows the Cul1-Rbx1 catalytic core to
continuously and rapidly sample the steady-state population
of FBP-Skp1 complexes. It has been proposed that cycling of
SCF complexes is driven by Nedd8 conjugation and decon-
jugation enzymes working in concert with the sequestration
factor Cand1. Deneddylation of the entire population of cullin
proteins occurs at a very fast rate, as indicated by rapid loss
of Nedd8 conjugates upon inhibition of NAE (4). Once it is
deneddylated, Cul1 can bind to the sequestration factor
Cand1, which displaces FBP-Skp1 (16, 17, 33). A core pre-
diction of this hypothesis is that in cells in which Nedd8
conjugation is abruptly halted, Cand1 should displace FBP-
Skp1 from deneddylated Cul1, and there should be net loss of
SCF complexes. By contrast, in quantitative mass spectrom-
etry experiments, we detected less Cand1 and more FBP-
Skp1 bound to Cul1 after incubation with the Nedd8 conju-
gation inhibitor MLN4924. We have shown that this is not
because of depletion of free Cand1 in MLN4924-treated cells
(Fig. 5). It is also unlikely that the nature or position of the
epitope tag is responsible for the persistence of SCF com-
plexes in MLN4924-treated cells because a similar result was
observed with a FLAG-HA tag appended to the N terminus of
cullins (J.W. Harper, personal communication). Notably, the
steady-state level of Nedd8-conjugated Cul1 was much
higher in the cell line employed by Harper and colleagues
(50% in HEK 293T versus 5–10% in our HEK 293 cells),
suggesting that the initial steady-state neddylation does not
determine the response to MLN4924.
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There are three possible explanations for this unexpected
effect of MLN4924 treatment on the Cul1 proteome: (i) syn-
thesis of most FBPs is slightly up-regulated upon MLN4924
treatment, (ii) MLN4924 shifts the equilibrium between free
Cul1-Rbx1 and FBP-Skp1 in favor of assembly, so there are
more SCF complexes even though the total level of FBPs
does not change, or (iii) degradation of most FBPs is re-
pressed upon MLN4924 treatment. The first explanation
seems unlikely because it would require a complex mecha-
nism to coordinate the simultaneous up-regulation of many
FBPs. The second explanation is intriguing, but as of yet there
is no evidence to support or discount it. The third explanation
is consistent with what is currently known about FBP auto-
regulation. Many FBPs have been shown to be unstable, and
degradation is often (34, 35), but not always (36, 37), depen-
dent on SCF activity, suggesting that auto-ubiquitination of
FBPs within SCF complexes underlies their turnover. Block-
ade of SCF activity with MLN4924 would be predicted to
suppress auto-ubiquitination-dependent turnover of FBPs. It
remains unclear why the deneddylated SCF complexes that
accumulated in MLN4924-treated cells were not disassem-
bled by Cand1, given that Cand1 can displace FBP-Skp1
from unmodified Cul1 in vitro (16, 17). It is possible that Cand1
does not possess this activity in vivo, or that Cand1 does
displace FBP-Skp1 modules from unmodified Cul1, but that
the reaction is freely reversible such that the overall equilib-
rium between Cand1, Cul1, and FBP-Skp1 does not change.
Future experiments should aim to distinguish between these
various possibilities.
In summary, we have investigated the Cul1 proteome using
high accuracy mass spectrometry. We found common shared
subunits Skp1 and Rbx1, regulators such as CSN, Dcund1, 2,
4, and 5 and Cand1 and 2, as well as 42 different FBPs
associated with Cul1. These F-box proteins exhibited substan-
tial differences in their abundance, and most of the abundant
F-box proteins remain to be characterized. Using a quantitative
SILAC approach, we observed, contrary to expectation, that
deneddylation leads to a net increase in SCF complexes. Our
results suggest that current models of the Cul1 cycle do not
adequately capture themechanisms that sculpt the repertoire of
SCF complexes in vivo. Future work will aim to understand how
Nedd8 deconjugation, FBP dissociation, and FBP turnover co-
operate to control the Cul1 cycle in cells.
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